Goldman Sachs’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.3M | Buy |
|
|||||
|
2025
Q1 | $1.46M | Sell |
|
|||||
|
2024
Q4 | $2.08M | Buy |
|
|||||
|
2024
Q3 | $873K | Buy |
|
|||||
|
2024
Q2 | $169K | Buy |
|
|||||
|
2024
Q1 | $116K | Sell |
|
|||||
|
2023
Q4 | $234K | Buy |
|
|||||
|
2023
Q3 | $146K | Sell |
|
|||||
|
2023
Q2 | $187K | Buy |
|
|||||
|
2023
Q1 | $181K | Buy |
|
|||||
|
2022
Q4 | $107K | Sell |
|
|||||
|
2022
Q3 | $165K | Sell |
|
|||||
|
2022
Q2 | $344K | Sell |
|
|||||
|
2022
Q1 | $766K | Sell |
|
|||||
|
2021
Q4 | $1.66M | Buy |
|
|||||
|
2021
Q3 | $1.57M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $312K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $9K | Buy |
|
|||||
|
2019
Q4 | $15K | Sell |
|
|||||
|
2019
Q3 | $28K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $147K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $71K | Sell |
|
|||||
|
2017
Q1 | $97K | Sell |
|
|||||
|
2016
Q4 | $61K | Buy |
|
|||||
|
2016
Q3 | $88K | Buy |
|
|||||
|
2016
Q2 | $63K | Sell |
|
|||||
|
2016
Q1 | $1.24M | Buy |
|
|||||
|
2015
Q4 | $1.24M | Buy |
|